238 related articles for article (PubMed ID: 18675600)
1. Determination of rivaroxaban--a novel, oral, direct Factor Xa inhibitor--in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Rohde G
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):43-50. PubMed ID: 18675600
[TBL] [Abstract][Full Text] [Related]
2. Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography-tandem mass spectrometry.
Blonk MI; van der Nagel BC; Smit LS; Mathot RA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):675-81. PubMed ID: 20138814
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Lu S; Jiang K; Qin F; Lu X; Li F
J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
[TBL] [Abstract][Full Text] [Related]
4. Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin.
Mani H; Rohde G; Stratmann G; Hesse C; Herth N; Schwers S; Perzborn E; Lindhoff-Last E
Thromb Haemost; 2012 Jul; 108(1):191-8. PubMed ID: 22534775
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study.
Sala F; Zucchetti M; Bagnati R; D'Incalci M; Pace S; Capocasa F; Marangon E
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3118-26. PubMed ID: 19695967
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.
Samama MM; Contant G; Spiro TE; Perzborn E; Guinet C; Gourmelin Y; Le Flem L; Rohde G; Martinoli JL;
Thromb Haemost; 2012 Feb; 107(2):379-87. PubMed ID: 22187012
[TBL] [Abstract][Full Text] [Related]
7. Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies.
Mendes GD; Hamamoto D; Ilha J; Pereira Ados S; De Nucci G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):553-9. PubMed ID: 17240203
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
[TBL] [Abstract][Full Text] [Related]
9. A novel and sensitive method for ethinylestradiol quantification in human plasma by high-performance liquid chromatography coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry: application to a comparative pharmacokinetics study.
Borges NC; Astigarraga RB; Sverdloff CE; Galvinas PR; da Silva WM; Rezende VM; Moreno RA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3601-9. PubMed ID: 19773204
[TBL] [Abstract][Full Text] [Related]
10. Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.
Douxfils J; Tamigniau A; Chatelain B; Chatelain C; Wallemacq P; Dogné JM; Mullier F
Thromb Haemost; 2013 Oct; 110(4):723-31. PubMed ID: 23846172
[TBL] [Abstract][Full Text] [Related]
11. A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of hydroxysafflor yellow A in human plasma: application to a pharmacokinetic study.
Wen A; Yang J; Jia Y; Yang Z; Tian Y; Wu Y; Wang Z; He Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):41-6. PubMed ID: 18964371
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatography-tandem mass spectrometry for the determination of pidotimod in human plasma and its application to a pharmacokinetic study.
Zhang Y; Xiong Z; Qin F; Lu S; Liu W; Li F
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2566-70. PubMed ID: 19604731
[TBL] [Abstract][Full Text] [Related]
14. Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tandem mass spectrometry.
Damen CW; Israëls T; Caron HN; Schellens JH; Rosing H; Beijnen JH
Rapid Commun Mass Spectrom; 2009 Mar; 23(6):763-74. PubMed ID: 19204931
[TBL] [Abstract][Full Text] [Related]
15. A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry.
Frankfort SV; Ouwehand M; van Maanen MJ; Rosing H; Tulner LR; Beijnen JH
Rapid Commun Mass Spectrom; 2006; 20(22):3330-6. PubMed ID: 17044120
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Lang D; Freudenberger C; Weinz C
Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
[TBL] [Abstract][Full Text] [Related]
17. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
[TBL] [Abstract][Full Text] [Related]
18. Determination of bergenin in human plasma after oral administration by HPLC-MS/MS method and its pharmacokinetic study.
Wang J; Wang BJ; Wei CM; Yuan GY; Zhang R; Liu H; Zhang XM; Guo RC
Biomed Chromatogr; 2009 Feb; 23(2):199-203. PubMed ID: 18816487
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems.
Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Príeto MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4035-41. PubMed ID: 19896423
[TBL] [Abstract][Full Text] [Related]
20. Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometry.
Farid NA; McIntosh M; Garofolo F; Wong E; Shwajch A; Kennedy M; Young M; Sarkar P; Kawabata K; Takahashi M; Pang H
Rapid Commun Mass Spectrom; 2007; 21(2):169-79. PubMed ID: 17154350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
